German technology SME applying computational modelling and big-data analytics to industrial process optimization and biotechnology enzyme discovery.
DIVIS is a German technology SME that applies data analytics and computational intelligence as a specialist tool within research consortia. In the CoPro project they contributed to optimizing production coordination across process industries, likely through software-based scheduling or decision-support systems. In the more recent EnXylaScope project, they shifted their computational skills toward biotechnology — applying big-data analysis and computational modelling to enzyme discovery and microbial bioprospecting for xylan degradation. Their consistent value proposition across both projects is translating complex, multi-variable data into actionable insights, regardless of whether the domain is industrial manufacturing or applied microbiology.
CoPro (2016–2020) focused on improving energy and resource efficiency through better coordination of production in the process industries, a natural fit for an intelligent solutions provider.
EnXylaScope (2021–2025) lists computational modelling as a core keyword, applied to the discovery and development of novel enzymes for xylan processing.
EnXylaScope credits big-data as a method, suggesting DIVIS contributes data pipeline or analysis infrastructure to multi-partner research projects.
EnXylaScope involves mining microbial diversity for novel enzymes (xylanases), a domain where DIVIS appears to provide computational screening and data interpretation support.
DIVIS entered the H2020 program focused squarely on manufacturing and process industries — CoPro (2016–2020) was about energy efficiency and production coordination, classic industrial software territory with no recorded biological or data-science keywords. By 2021, the focus had rotated substantially: EnXylaScope brought them into food biotechnology and life sciences, with all recorded keywords (enzymes, bioprospecting, xylan, big-data, computational modelling) being entirely absent from their earlier work. The through-line is computational intelligence, but the application domain has clearly shifted from factory floors toward biological data and enzyme engineering pipelines.
DIVIS appears to be repositioning its computational and data capabilities toward life sciences and biotechnology, making them a candidate partner for future projects at the intersection of bioinformatics, food biotechnology, and industrial enzyme applications.
DIVIS has participated in two projects and coordinated neither — they are consistently a specialist contributor rather than a project driver. Both projects placed them inside large international consortia (averaging 16+ partners each), suggesting they are recruited for a specific technical capability rather than for their network or management capacity. This profile points to an organization that works best when plugged into a well-structured consortium that needs computational or data intelligence as one component of a larger effort.
Despite only two projects, DIVIS has connected with 32 unique consortium partners across 15 countries — a sign of participation in large, pan-European RIA consortia rather than small bilateral arrangements. No geographic clustering is evident from the available data.
DIVIS is one of few SMEs that has successfully bridged industrial process optimization and biotechnology research within H2020, contributing computational tools to both domains. For a consortium builder, they offer genuine cross-sector versatility — the same data-modelling skills that optimize a chemical plant can be redirected to screen microbial enzyme libraries. As a Dortmund-based SME with a focused technical niche, they likely offer more agility and domain depth than a generalist IT consultancy, while being a lower-cost partner than a university research group.
